Barbet J - Search Results

1

Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.

Huclier-Markai S, Alliot C, Varmenot N, Cutler CS, Barbet J. Huclier-Markai S, et al. Among authors: barbet j. Curr Top Med Chem. 2012;12(23):2642-54. doi: 10.2174/1568026611212230002. Curr Top Med Chem. 2012. PMID: 23339760 Review.

2

Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapy.

Huclier-Markai S, Grivaud-Le Du A, N'tsiba E, Montavon G, Mougin-Degraef M, Barbet J. Huclier-Markai S, et al. Among authors: barbet j. J Chromatogr A. 2018 Oct 26;1573:107-114. doi: 10.1016/j.chroma.2018.08.065. Epub 2018 Sep 1. J Chromatogr A. 2018. PMID: 30224278

3

Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasies.

Barbet J, Huclier-Markai S. Barbet J, et al. Pharm Stat. 2019 Oct;18(5):513-525. doi: 10.1002/pst.1943. Epub 2019 Apr 12. Pharm Stat. 2019. PMID: 30977282

4

Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.

Huclier-Markai S, Kerdjoudj R, Alliot C, Bonraisin AC, Michel N, Haddad F, Barbet J. Huclier-Markai S, et al. Among authors: barbet j. Nucl Med Biol. 2014 May;41 Suppl:e36-43. doi: 10.1016/j.nucmedbio.2013.11.004. Epub 2013 Nov 16. Nucl Med Biol. 2014. PMID: 24361353

5

Is there an interest to use deuteron beams to produce non-conventional radionuclides?

Alliot C, Audouin N, Barbet J, Bonraisin AC, Bossé V, Bourdeau C, Bourgeois M, Duchemin C, Guertin A, Haddad F, Huclier-Markai S, Kerdjoudj R, Laizé J, Métivier V, Michel N, Mokili M, Pageau M, Vidal A. Alliot C, et al. Among authors: barbet j. Front Med (Lausanne). 2015 May 11;2:31. doi: 10.3389/fmed.2015.00031. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26029696 Free PMC article. Review.

6

The ARRONAX project.

Haddad F, Barbet J, Chatal JF. Haddad F, et al. Among authors: barbet j. Curr Radiopharm. 2011 Jul;4(3):186-96. doi: 10.2174/1874471011104030186. Curr Radiopharm. 2011. PMID: 22201708 Review.

7

Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction.

Bourgeois M, Guerard F, Alliot C, Mougin-Degraef M, Rajérison H, Remaud-Le Saëc P, Gestin JF, Davodeau F, Chérel M, Barbet J, Faivre-Chauvet A. Bourgeois M, et al. Among authors: barbet j. J Labelled Comp Radiopharm. 2008 Oct 15;51(11):379-83. doi: 10.1002/jlcr.1543. Epub 2008 Sep 24. J Labelled Comp Radiopharm. 2008. PMID: 26148336

8

ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.

Haddad F, Ferrer L, Guertin A, Carlier T, Michel N, Barbet J, Chatal JF. Haddad F, et al. Among authors: barbet j. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1377-87. doi: 10.1007/s00259-008-0802-5. Epub 2008 May 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18465127

9

(211)At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds.

Ayed T, Pilmé J, Tézé D, Bassal F, Barbet J, Chérel M, Champion J, Maurice R, Montavon G, Galland N. Ayed T, et al. Among authors: barbet j. Eur J Med Chem. 2016 Jun 30;116:156-164. doi: 10.1016/j.ejmech.2016.03.082. Epub 2016 Mar 29. Eur J Med Chem. 2016. PMID: 27061979

10

Recent advances in pretargeted radioimmunotherapy.

Gruaz-Guyon A, Raguin O, Barbet J. Gruaz-Guyon A, et al. Among authors: barbet j. Curr Med Chem. 2005;12(3):319-38. doi: 10.2174/0929867053363225. Curr Med Chem. 2005. PMID: 15723622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page